SKIN (STOCKS)
The Beauty Health Company Class A Common Stock
$0.940000
+0.042200 (+4.70%)
Prev close: $0.897800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Pedro Malha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $120.17M
- Employees
- 769
- P/E (TTM)
- -4.67
- P/B (TTM)
- 1.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
8
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.05 | -0.0075 | -14.29% |
|
Sep 2025 (Q3)
|
$-0.09 | $-0.07 | -0.0209 | -30.25% |
|
Jun 2025 (Q2)
|
$0.03 | $-0.05 | +0.0839 | +155.66% |
|
Mar 2025 (Q1)
|
$-0.08 | $-0.13 | +0.0488 | +37.89% |
Financial Statements
| Revenues | $300.79M |
| Benefits Costs and Expenses | $306.73M |
| Cost Of Revenue | $104.43M |
| Costs And Expenses | $306.73M |
| Gross Profit | $196.36M |
| Operating Expenses | $217.17M |
| Research and Development | $5.63M |
| Other Operating Expenses | $211.54M |
| Operating Income/Loss | -$20.80M |
| Income/Loss From Continuing Operations After Tax | -$9.52M |
| Income/Loss From Continuing Operations Before Tax | -$5.94M |
| Income Tax Expense/Benefit | $3.58M |
| Income Tax Expense/Benefit, Current | $1.70M |
| Income Tax Expense/Benefit, Deferred | $1.88M |
| Net Income/Loss | -$9.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.52M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.08 |
| Diluted Earnings Per Share | -$0.16 |
| Basic Average Shares | 126,378,509 |
| Diluted Average Shares | 135,798,202 |
| Assets | $499.80M |
| Current Assets | $309.52M |
| Inventory | $48.01M |
| Other Current Assets | $261.51M |
| Noncurrent Assets | $190.29M |
| Liabilities | $438.75M |
| Current Liabilities | $186.28M |
| Accounts Payable | $15.63M |
| Wages | $24.95M |
| Other Current Liabilities | $145.70M |
| Noncurrent Liabilities | $252.47M |
| Equity | $61.06M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $61.06M |
| Liabilities And Equity | $499.80M |
| Net Cash Flow From Operating Activities | $37.49M |
| Net Cash Flow From Operating Activities, Continuing | $37.49M |
| Net Cash Flow From Investing Activities | -$5.16M |
| Net Cash Flow From Investing Activities, Continuing | -$5.16M |
| Net Cash Flow From Financing Activities | -$174.93M |
| Net Cash Flow From Financing Activities, Continuing | -$174.93M |
| Exchange Gains/Losses | $5.21M |
| Net Cash Flow | -$137.39M |
| Net Cash Flow, Continuing | -$142.60M |
| Comprehensive Income/Loss | -$4.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.00M |
| Other Comprehensive Income/Loss | -$4.00M |